​
​

Inhibrx Biosciences (INBX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Inhibrx Biosciences Revenue Highlights

Latest Revenue (Y)

$1.80M

0

Main Segment (Y)

License, Non-Affiliate

Inhibrx Biosciences Revenue by Period

Inhibrx Biosciences Revenue by Year

DateRevenueChange
2023-12-31$1.80M-17.36%
2022-12-31$2.18M-69.43%
2021-12-31$7.13M-44.37%
2020-12-31$12.81M40.86%
2019-12-31$9.09M21.24%
2018-12-31$7.50M-5.66%
2017-12-31$7.95M-

Inhibrx Biosciences generated $1.80M in revenue during NA 2023, up -17.36% compared to the previous quarter, and up 24.00% compared to the same period a year ago.

Inhibrx Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$100.00K100.00%
2024-03-31--100.00%
2023-12-31$1.63M1273.11%
2023-09-30$119.00K296.67%
2023-06-30$30.00K76.47%
2023-03-31$17.00K-93.80%
2022-12-31$274.00K-1.44%
2022-09-30$278.00K-60.90%
2022-06-30$711.00K-22.30%
2022-03-31$915.00K-67.74%
2021-12-31$2.84M13.08%
2021-09-30$2.51M173.20%
2021-06-30$918.00K6.37%
2021-03-31$863.00K-68.91%
2020-12-31$2.78M-52.35%
2020-09-30$5.83M74.75%
2020-06-30$3.33M282.34%
2020-03-31$872.00K226.59%
2019-12-31$267.00K-66.37%
2019-09-30$794.00K-20.60%
2019-06-30$1.00M-85.78%
2019-03-31$7.03M181.28%
2018-06-30$2.50M-
2018-03-31$2.50M-

Inhibrx Biosciences generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Inhibrx Biosciences Revenue Breakdown

Inhibrx Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20
License, Non-Affiliate$1.80M$2.18M$10.81M-
License-$2.18M--
Grant-$14.00K$86.00K-
License, Affiliate - PD-L1 And 4-1BB License Agreement----
License, Affiliate - OX40 License Agreement---$2.00M
License, Affiliate---$2.00M

Inhibrx Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: License, Non-Affiliate (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
License, Non-Affiliate$100.00K$1.75M$30.00K$17.00K$278.00K$711.00K$915.00K$2.51M$918.00K$863.00K$3.83M---
Grant-------$14.00K$20.00K$24.00K$36.00K$26.00K$300.00K-
License----$274.00K$2.84M--------
License, Affiliate - OX40 License Agreement-------------$2.00M
License, Affiliate-------------$2.00M
License, Affiliate - PD-L1 And 4-1BB License Agreement--------------

Inhibrx Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License, Non-Affiliate (100.00%).

Inhibrx Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTGXProtagonist Therapeutics$60.00M$4.67M
MRUSMerus$43.95M$11.77M
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
KRONKronos Bio$6.29M$2.37M
CRNXCrinetics Pharmaceuticals$4.01M-
INBXInhibrx Biosciences$1.80M-
VRDNViridian Therapeutics$314.00K$86.00K
LYELLyell Immunopharma$130.00K$34.00K
OPTOpthea$108.41K$61.27K
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
DICEDICE Therapeutics--
ELYMEliem Therapeutics--
CELCCelcuity--
MLYSMineralys Therapeutics--
LRMRLarimar Therapeutics--
MACKMerrimack Pharmaceuticals--
GLUEMonte Rosa Therapeutics-$4.70M
ELVNEnliven Therapeutics--

INBX Revenue FAQ

What is Inhibrx Biosciences’s yearly revenue?

Inhibrx Biosciences's yearly revenue for 2023 was $1.8M, representing a decrease of -17.36% compared to 2022. The company's yearly revenue for 2022 was $2.18M, representing a decrease of -69.43% compared to 2021. INBX's yearly revenue for 2021 was $7.12M, representing a decrease of -44.37% compared to 2020.

What is Inhibrx Biosciences’s quarterly revenue?

Inhibrx Biosciences's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $100K, a 100.00% increase from the previous quarter (Q1 2024), and a 233.33% increase year-over-year (Q2 2023). INBX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Inhibrx Biosciences’s revenue growth rate?

Inhibrx Biosciences's revenue growth rate for the last 3 years (2021-2023) was -74.74%, and for the last 5 years (2019-2023) was -80.20%.

What are Inhibrx Biosciences’s revenue streams?

Inhibrx Biosciences's revenue streams in c 23 are License, Non-Affiliate

What is Inhibrx Biosciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Inhibrx Biosciences was License, Non-Affiliate. This segment made a revenue of $1.8M, representing 100.00% of the company's total revenue.